PainChek Ltd
ASX:PCK
PainChek Ltd
ASX:PCK
Price:
0.028 AUD
-3.45%
Market Closed
Updated:
May 6, 2024
Section:
Relative Value
The Relative Value of one
PCK
stock under the Base Case scenario is
0.004
AUD.
Compared to the current market price of 0.028 AUD,
PainChek Ltd
is
Overvalued by 86%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PCK
Relative Value
Base Case
0.004
AUD
Overvaluation 86%
Valuation Multiples
Multiples Across Competitors
PCK Competitors Multiples
PainChek Ltd Competitors
PainChek Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
PainChek Ltd
ASX:PCK
|
45.8m AUD | 18.5 | -5.9 | -5.6 | -5.6 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.6B USD | 13.8 | 62.2 | 62.3 | 67 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
11.7B AUD | 79.9 | 167.6 | 115.3 | 115.3 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
7.4B USD | 11.9 | -350.6 | -184.9 | -171.9 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 4.8 | 24.1 | 12.5 | 14.1 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 9.5 | 32.4 | 21.8 | 23.2 | |
| SE |
|
Sectra AB
STO:SECT B
|
42.5B SEK | 25.9 | 100 | -66 | -66 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.6 | -21.6 | 25.6 | 272.8 | |
| US |
|
Certara Inc
NASDAQ:CERT
|
2.8B USD | 7.9 | -50.5 | 46 | 461.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
